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Abstract
Background
The neuropsychological consequences of exposure to environmental hypobaric hypoxia
(EHH) remain unclear. We thus investigated them in a large group of healthy volunteers
who trekked to Mount Everest base camp (5,300 m).
Methods
A neuropsychological (NP) test battery assessing memory, language, attention, and execu-
tive function was administered to 198 participants (age 44.5±13.7 years; 60% male). These
were studied at baseline (sea level), 3,500 m (Namche Bazaar), 5,300 m (Everest Base
Camp) and on return to 1,300 m (Kathmandu) (attrition rate 23.7%). A comparable control
group (n = 25; age 44.5±14.1 years; 60% male) for comparison with trekkers was tested at/or
near sea level over an equivalent timeframe so as to account for learning effects associated
with repeat testing. The Reliable Change Index (RCI) was used to calculate changes in cogni-
tion and neuropsychological function during and after exposure to EHH relative to controls.
Results
Overall, attention, verbal ability and executive function declined in those exposed to EHH
when the performance of the control group was taken into account (RCI .05 to -.95) with
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decline persisting at descent. Memory and psychomotor function showed decline at highest
ascent only (RCI -.08 to -.56). However, there was inter-individual variability in response:
whilst NP performance declined in most, this improved in some trekkers. Cognitive decline
was greater amongst older people (r = .42; p < .0001), but was otherwise not consistently
associated with socio-demographic, mood, or physiological variables.
Conclusions
After correcting for learning effects, attention, verbal abilities and executive functioning
declined with exposure to EHH. There was considerable individual variability in the response
of brain function to sustained hypoxia with some participants not showing any effects of hyp-
oxia. This might have implications for those facing sustained hypoxia as a result of any
disease.
Introduction
Tissue hypoxia occurs in response to a diverse range of acute and chronic disease conditions
[1] and may impact on neurocognitive outcome [2]. Mild to moderate perioperative hypoxae-
mia is also implicated in the pathogenesis of postoperative cognitive impairment [3], and
cognitive impairment is recognised in those suffering conditions associated with chronic
hypoxaemia, such as chronic obstructive pulmonary disease and obstructive sleep apnea [4].
However, apparently normal cognition (as evidenced by effective completion of tasks) is possi-
ble in the face of profound hypoxaemia [5] while the role of confounding factors and preexist-
ing vulnerabilities (such as older age, comorbidity, and/or frailty) in the pathogenesis of
cognitive decline cannot be completely elucidated in studies involving patient populations.
Research on healthy volunteers offers the opportunity to explore the direct effects of hyp-
oxia on cognition and to identify pathways and avenues for neuroprotection [6,7,8]. Prior
work has been instrumental in delineating the cognitive domains most affected [9] yet limited
by small sample sizes, restricted ranges of neuropsychological tests, and lack of control groups
and/or of serial assessments [8, 10, 11, 12, 13, 14, 15]. Importantly, improvements in neuropsy-
chological test performance, which occur with repeat testing (“practice effects”) can mask
declines in cognitive functioning [16, 17, 18] and such effects are rarely adjusted for.
As part of the Caudwell Extreme Everest Medical Research Expedition (February 2007 –
June 2007), we compared cognitive function in a large sample of healthy participants exposed
to environmental hypobaric hypoxia (EHH) during a trek to the base camp of Mount Everest
with a comparator group assessed at the same time points at or near sea level [19, 20]. We also
sought to identify trajectories of cognitive function across ascent and examined the associa-
tions between cognitive performance and concurrently assessed physiological parameters.
Methods
Participants
Participants were recruited from the general public. Inclusion criteria were: age over 18; fluent
English speaker; lowland resident; non-professional trekker status; availability for baseline test-
ing; and good physical health (determined by two health-screening tests). Excluded were those
with recent (i.e., 3 months pior to departure) altitude exposure (e.g. trekking, skiing) [20]. To
estimate the magnitude of practice effects, we used the same inclusion criteria to enroll a
group of control participants who did not ascend to altitude. Control participants were
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recruited opportunistically (snowball sampling [21]) through network of acquaintances, co-
workers of trekkers and researchers.
Written informed consent was obtained from all participants. The University College Lon-
don Research Ethics Committee approved all study procedures (in accordance with the Decla-
ration of Helsinki).
Experimental protocol/course of expedition
A detailed ascent profile is provided in “Design and Conduct of Caudwell Xtreme Everest: An
Observational Cohort Study of Variation in Human Adaptation to Progressive Environmental
Hypoxia” [18]. In brief, all participants were initially studied at sea level in London, UK (75
m), and then followed an identical 11-day ascent route to Everest Base Camp (EBC). Subjects
were assessed at 3500 m (Namche), 5300 m (EBC) and at 1300 m (upon return to Kathmandu).
Laboratory altitudes, barometric pressures and inspired partial pressures of oxygen are sum-
marised in Table 1. The ascent rate was chosen to minimise the incidence of high altitude ill-
ness and therefore maximise the number of participants able to contribute data.
Each subject underwent neurocognitive assessment consistently on either day 1 or day 2
after arrival at each point. The control group underwent neuropsychological testing at sea level
at the same time intervals as the trekkers.
Measures
Self-reported demographical data (age, gender, education) were recorded. Resting diastolic
and systolic blood pressure (DBP/SBP [mmHg]; Omron M7, Bannockburn, IL, USA), heart
rate [HR, bpm], Near Infrared Spectroscopy of cerebral frontal lobes bilaterally (NIRS–rSO2/%
Invos Cerebral Oximeter 5100C, Somanetics, Troy, MI, USA), haemoglobin concentration in
venous blood (g/l) (Hemocue AB, Hemocue, Sweden), percentage saturation of arterial hae-
moglobin with oxygen (SaO2 (%), Nonin Onyx 9500, Nonin Medical Inc, MN, USA), maximal
exertional oxygen consumption (ml/kg/min via cardio-pulmonary exercise testing; Metamax
3b, Cortex, Leipzeig, Germany) and anthropometric indices (weight (kg); height (cm)) were
recorded at all assessments except for last assessment at Kathmandu. See [19] for details.
Cognitive/neuropsychological tests and mood assessments. The neuropsychological
assessment test battery was assembled to include all major cognitive domains–attention, mem-
ory, executive function, and language–using standardised and commonly used tests in clinical
and research settings [22]: Trail Making Test parts A and B [23], Controlled Oral Word Asso-
ciation Test [24], Letter Cancellation Test [22, 25], Stroop Test [26], Grooved Pegboard [27],
Rey Auditory Verbal Learning Test [28], Symbol Digit Modalities Test [29] and Block Design
Test [30] (see Table 2 for description). Alternate forms of the tests were used when available
[22]. Tests were administered in a fixed order by trained research personnel. Intelligence (IQ)
testing (using the Wechsler Intelligence Test [30]) was only performed at baseline.
The Brief Center for Epidemiologic Studies Depression Scale [31] and State Trait Anxiety
Inventory [32] measured depression and anxiety symptoms respectively. Symptoms of Acute
Mountain Sickness (AMS) were evaluated using the Lake Louise Symptoms Score [33].
Table 1. Laboratory altitude, mean barometric pressure, mean laboratory temperature & inspired partial pressure of oxygen.
Appx Altitude metres Ambient Temperature ˚C Barometric Pressure mmHg PiO2 mmHg
LONDON 75 24.1 (1) 754 (10) 148.0
NAMCHE 3500 19.6 (2.6) 505(3) 95.4
EBC 5300 21.5 (5.6) 404 (3) 74.7
KATHMANDU 1300 26.1 (1.5) 650 (3) 126.2
https://doi.org/10.1371/journal.pone.0174277.t001
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Statistical analysis
In order to assess change at a group level, cognitive outcomes were compared between baseline
and follow-up assessments for the trekker and control groups using a series of mixed factor
analyses of variance. Three analyses were performed. The first compared group differences in
changes of performance of each of the neuropsychological tests. The second and most critical
analyses utilized the scores of the control group in constructing a practice adjusted Reliable
Change Index (RCI) method [34, 18] to adjust individual differences in test scores for mea-
surement error and practice effects. RCIs were determined by subtracting the baseline score
(X1) from the follow up scores (X2), giving (DELTA)X for each individual participant for a
given task. The mean measured change for the controls, (DELTA)Xc, calculated in the same
way, was then subtracted from this, removing any practice effect. This score was then divided
by the within-subject standard deviation for control group, controlling for expected variability.
This formula gives a precise estimate of relative change controlling for variability and prac-
tice–it is comparable with various regression based estimates and clearly superior to simple
change scores in ability reliable and clinically meaningful change [18]
These RCI scores were then used to create individual and combined test scores (Zcombined)
using the sum of standardized RCI scores (z RCI) for each test divided by the standard devia-
tion of this summation in the control group. This technique identifies cognitive change by
comparing the changes in test scores of an individual trekker with changes in the test scores of
Table 2. Description of Neuropsychological Tests.
NP Tests Cognitive domains Test description Performance measures
Wechsler Intelligence
Test
General intelligence Battery of verbal and performance based tasks to
provide IQ scores
Full IQ score; Verbal IQ score; Performance IQ
score
Trail Making Test
Part A (TMT-A)1
Attention / concentration Connect 25 consecutive numbers in correct order
as fast as possible
Time to completion (s)
Trail Making Test
Part B (TMT-B)1
Attention and executive
function
Efficiently alternate between sequential list of
numbers & letters
Time to completion (s)
Symbol Digit
Modality Test1
(SDMT)
Attention / concentration Visual scanning & rapid written response in
substituting symbols for numbers according to
learned code
No correct substitutions within 90 seconds
Letter Cancellation
Test (LCT)
Attention / visual
scanning and mental
speed
Ability to visual scan & cancel designated letters in
working sheets of randomly allocated letters as
fast as possible
Time to completion
Block Design (BD) Visuo-spatial and motor
skills; non-verbal problem
solving
Ability to reproduce designs of increasing difficulty
using blocks
Time to completion
Rey Auditory Verbal
Learning Test1
Learning and verbal
memory
Ability to retain and recall words Total of correct recalls across 5 trials (verbal
learning score) (RAVLT-L). Total words recalled
after distraction (delayed recall score) (RAVLT-D)
Stroop Color Word
Test
Attention and executive
function
Part 1: To read color words and disregard color
ink. Part 2. To name the color in which the color
names are printed and disregard their verbal
content
Time to completion (Part 2; color word task)
Controlled Oral Word
Association1
(COWA)
Verbal ability / verbal
fluency
Ability to make verbal associations to specified
letters
Total of correct words beginning with the
designated letters over 1 minute trials
Grooved Pegboard Psychomotor speed and
manual dexterity
Ability to perform the task of picking and placing
pegs onto board varying in orientation using 1
hand
Time to completion in seconds (dominant (GP-D)
and non-dominant (GP-ND) hands measured
separately)
Note
1 Alternate forms used
https://doi.org/10.1371/journal.pone.0174277.t002
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the control group over the same interval. The sign was adjusted so that negative z scores indi-
cated deterioration from the baseline test. In the third analysis, the RCI scores were examined
for each individual to determine the percentage of individuals who demonstrated a decline in
performance for each test (i.e., negative RCI).
To further examine patterns of cognitive performance, Latent Profile Analysis (LPA) was
conducted on total/combined RCI scores in Mplus Version 6.12 [34]. An increasing number
of classes were fit in a series of iterative steps until the resultant model was not well identified
[35]. The optimal number of classes was determined using the Akaike Information Criterion
(AIC) [36], Bayesian Information Criterion (BIC) [37], and the Bootstrapped Likelihood Ratio
Test (BLRT) [38, 39]. We sought a model with lower values for the information criteria, and
p values .05 for the likelihood ratio test. In addition, classification quality was indicated by
higher relative entropy ( .80), average posterior class probability (.70), and odds of correct
classification ( 5) [40, 41,42]. The associations between cognitive change indices (individual
RCI; and trajectories of total RCI scores) to demographic and clinical parameters were explored
using correlations or ANOVA (as appropriate). For physiological parameters, both absolute lev-
els as well the percentile change at each ascent point relative to baseline were employed.
To control for missing data, we repeated all analyses using all cases enrolled at baseline after
missing data imputation (last value carried forward approach) as a sensitivity analysis. Signifi-
cance levels were set at p< .05. All values reported are mean ± SD unless stated otherwise.
Results
One hundred and ninety-eight trekker participants (44.7±13.7 years; 63% male; years of full
time education = 17.1±2.3; Weight (kg) = 79.99±13.52; Height (cm) = 172.68±9.18) and 25
control participants (44.5±14.1 years; 60% male; years of full time education = 16.8±2.9) were
studied. Trekker and control groups were comparable in their demographic characteristics
(p> .05 in all cases). Complete cognitive data across all four assessments were obtained in
N = 153 trekkers (attrition rate = 23.7%) with data missing from N = 12 at Namche, N = 23 at
EBC, and N = 48 on return to Kathmandu. Reasons for missing data included poor health/
injury or tiredness (N = 33), logistic difficulties such as weather conditions or delayed flights
(N = 42), withdrawal (N = 1) and inability to complete for other reasons such as preoccupation
with other concerns (N = 7).
The characteristics and baseline neuropsychological performance of the trekkers who pro-
vided data for analysis of cognitive outcomes across all four assessments were comparable to
those of the total sample and the non-completers (p> .05 in all cases), indicating that the miss-
ing data did not reflect a selective loss to follow up. Details of physiological parameters and
symptoms across ascent are depicted in Table 3.
Group comparisons on cognition
Mean neuropsychological scores for both trekkers and control groups were within the refer-
ence range for all NP tests (within one standard deviation (SD) of general population test
norms) [43] (see Table 4 for mean scores).
Trekkers and controls had equivalent NP scores with the exception of RAVLT-Total, where
control subjects outperformed trekkers on all assessments including baseline. Generally, mean
cognitive performance across NP tests was significantly better from baseline to follow-up assess-
ments in both trekkers and controls, albeit not uniformly for all tests, providing evidence of the
expected practice effects with repeated NP administrations over short time intervals (p values<
.05). Post-hoc tests showed that performance improvements over repeat assessments were
greater in the control group relative to trekkers where slopes were less steep but still significant.
Caudwell Xtreme Everest: A study of the effects of environmental hypoxia on cognitive functioning
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As expected, evidence of a significant decline in raw NP scores at the group level was not
revealed on any of the neuropsychological tests for either group.
Course of cognition using reliable cognitive change index (RCI)
Data are summarized in Table 5. Controlling for practice effects using RCI methodology dem-
onstrated an altitude-related decline in cognitive performance for the trekkers. Mean RCI
scores revealed cognitive decline with ascent for all tasks except for the GP-D, GP-ND and
Table 3. Symptoms and physiological measurements across assessments.
London (sea level) Namche EBC Kathmandu
M (SD) M (SD) M (SD) M (SD)
Resting SPB+ 1.02 (20.33) 136.63 (17.41) 147.08 (20.14)
Resting DSB+ 78.90 (10.45) 85.04 (10.06) 89.52 (10.60)
Heart Rate (HR, bpm) 1 71.48 (13.58) 74.85 (12.86) 76.09 (13.85)
Hemoglobin (Hb, g/l) 1 144.78 (12.46) 147.23 (13.20) 157.67 (13.58)
SaO2 (%)1 97.60 (1.96) 88.61 (3.72) 77.70 (5.26)
NIRS–rSO2/%1 68.57 (8.35) 58.80 (7.44) 53.68 (7.32)
Maximal exertional oxygen consumption (ml/kg/min) .375 (.077) .394 (.079) .403 (.082)
LLS2 2.31 (2.26) 2.93 (2.40)
Anxiety 30.84 (8.06) 32.25 (8.53) 34.05 (10.87) 25.64 (6.78)
Depression 7.12 (6.48) 7.77 (5.68) 11.32 (7.72) 9.19 (7.19)
Note: SBP, systolic blood pressure; DPB, diastolic blood pressure; HR, heart rate; NIRS, Near Infrared Spectroscopy; SaO2, percentage saturation of
arterial haemoglobin with oxygen; Hb, Hemoglobin; LLS, Lake Louise Symptoms Score.
1 Physiological measurements were not taken at descent to Kathmandu.
2 LLS was not taken at baseline and descent to Kathmandu.
https://doi.org/10.1371/journal.pone.0174277.t003
Table 4. Absolute NP scores (Mean and Sd) across ascent & descent points for trekkers and controls.
BASELINE NAMCHE EVEREST BASE CAMP KATHMANDU
Trekkers Controls Trekkers Controls Trekkers Controls Trekkers Controls
TMT A1 24.68 (7.72) 29.44 (7.20) 27.28 (7.78) 28.10 (7.95) 21.98 (6.75) 25.40 (8.17) 20.34 (6.29) 21.95 (5.12)
TMT B1 50.17 (17.43) 57.80 (19.63) 50.85 (14.37) 49.10 (12.25) 48.66 (16.99) 49.05 (16.63) 41.43 (18.42) 46.05 (16.57)
COWA2 45.56 (12.28) 44.64 (9.05) 42.95 (12.14) 44.95 (11.16) 47.61 (13.89) 50.60 (11.39) 48.06 (12.13) 52.25 (12.38)
LCT1 72.12 (17.73) 80.32 (16.96) 86.92 (18.40) 86.86 (17.34) 76.66 (18.06) 79.00 (15.49) 76.94 (21.63) 74.65 (14.79)
Stroop CW1 114.88 (25.89) 116.36 (29.94) 108.37 (22.25) 102.52 (21.73) 104.08 (22.86) 95.95 (21.59) 102.06 (22.05) 95.15 (16.68)
GP D1 65.10 (12.55) 62.84 (10.19) 61.32 (10.45) 61.90 (10.12) 62.51 (10.93) 59.75 (11.22) 59.43 (10.34) 57.55 (8.71)
GP ND1 70.81 (12.55) 70.08 (12.17) 65.30 (10.60) 66.15 (11.01) 69.11 (12.06) 65.32 (12.46) 65.69 (12.55) 64.05 (10.07)
RAVLT- T2 54.05 (8.22) 59.72 (9.48) 59.58 (8.97) 64.95 (9.18) 57.24 (9.32) 63.70 (10.34) 57.87 (10.08) 63.40 (12.71)
RAVLT- Da -1.45 (1.86) -2.16 (2.23) -.95 (1.69) -.43 (.75) -1.67 (1.96) -1.40 (1.98) -1.69 (2.09) -2.15 (1.87)
Symbol Digit2 58.79 (10.06) 56.64 (10.07) 59.57 (11.39) 61.38 (8.95) 62.09 (13.15) 62.95 (10.59) 64.10 (14.27) 66.25 (11.85)
Block Design2 3 39.86 (8.37) 34.80 (10.65) - - 40.99 (8.54) 39.70 (8.11) 42.39 (10.08) 41.20 (8.82)
Note: TMT A, Trail Making Test, Form A; TMT B, Trail Making Test, Form B; LCT, letter cancellation test; SDTM–W, Symbol Digit Modality Test written
administration; RAVLT–T, Rey Auditory Verbal Learning Test total word recall after Trials 1–5; RAVLT–D, Rey Auditory Verbal Learning Test drop in
retention from Trials 5 to 7; GP–DOM, Grooved Pegboard dominant hand; GP–NDOM, Grooved Pegboard non dominant hand.
1 Time to completion in seconds (i.e. higher scores worse NP performance)
2 Number correct (i.e. higher scores better NP performance)
3 Drop in number of words recalled (i.e. higher scores worse NP performance).
a The Block Design was not performed in Namche.
https://doi.org/10.1371/journal.pone.0174277.t004
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RAVLT-L, which only deteriorated at the highest altitude (i.e., Everest Base Camp) (Table 4).
Inspection of RCI values indicated that there was a greater decline for most of tests at the first
ascent point (Namche). Decline was noted in all tests at EBC and persisted on return to Kath-
mandu for all domains but for GP-D, GP-ND and RAVLT-L. Decline was more pronounced
in tests of verbal ability/language (e.g. COWA; LCT) and executive function (e.g. BD; TMT-B)
whereas test of psychomotor function and verbal memory were only affected at highest ascent.
Sensitivity analyses using missing data imputation indicated a similar pattern of decline as that
identified in the primary analysis above.
Incidence of cognitive decline
Individual variability in performance was assessed by classifying individual participant RCIs
as either declined or not declined on each of the individual NP tests. With practice effects
accounted for, between two thirds and three quarters of trekkers demonstrated decline in indi-
vidual NP tests (see Table 4 above; see S1 Fig and S2 Fig). The mean number of test scores
showing decline was comparable across ascent points but varied across trekkers. The mean
number of test scores showing a decline was 5.38±2.28 (range = 10) in Namche; at EBC the
mean was 6.23± 2.49 test scores (range = 9) whereas in Kathmandu, decline was noted in 5.15
±3.42 (range = 11) NP test scores.
The latent profile analysis of summary NP scores indicated similar decline rates. In this
analysis, one- to three-class solutions were fit in a series of iterative steps to determine the opti-
mal number of profiles (the four-class solution was not well-identified). Model fit improved as
the number of classes increased (Table 6). As a result, the three-class solution was selected.
This solution demonstrated good relative entropy (.82), average posterior class probabilities
(.91–.93) and odds of correct classification (7.23–48.49). The three distinct profiles of cognitive
Table 5. Group mean (SD) and % of trekkers showing cognitive decline on the RCI individual and summary neuropsychological scores.
Namche EBC Kathmandu
M (SD) % Trekkers decline M (SD) % Trekkers decline M (SD) % Trekkers decline
TMT A1 -.69 (1.38) 72.3% -.16 (1.30) 64.8% -.41 (.82) 74.4%
TMT B1 -.80 (1.42) 79.8% -.63 (.155) 74.2% -.05 (.79) 58.2%
COWA2 -.72 (1.76) 69.5% -.72 (1.45) 74.6% -.83 (1.17) 76.9%
LCT1 -.75 (1.66) 72.8% -.54 (1.59) 67.1% -.95 (1.48) 76.1%
Stroop1 -.17 (1.15) 62.4% -.24 (.99) 66.2% -.30 (.90) 67.3%
GP D1 1.13 (2.61) 38% -.15 (2.29) 56.8% .12 (1.74) 49.1%
GP ND1 .56 (1.36) 38% -.32 (2.44) 64.8% .24 (1.71) 37.3%
RAVLT-L2 .06 (1.64) 46.5% -.08 (1.79) 60.6% .14 (1.46) 44.7%
RAVLT-D3 -.48 (1.42) 73.2% -.56 (2.39) 73.2% -.47 (1.91) 61.6%
Symbol Digit2 -.60 (1.32) 80.8% -.14 (1.29) 63.4% -.43 (1.03) 70%
Block Design2 a - - -.87 (1.06) 84.5% -.74 (.95) 83.7%
Total RCI a -.25 (.62) 76.1% -.36 (.71) 77% -.27 (.49) 69.3%
Note: TMT A, Trail Making Test, Form A; TMT B, Trail Making Test, Form B; LCT, letter cancellation test; SDTM–W, Symbol Digit Modality Test written
administration; RAVLT–T, Rey Auditory Verbal Learning Test total word recall after Trials 1–5; RAVLT–D, Rey Auditory Verbal Learning Test drop in
retention from Trials 5 to 7; GP–DOM, Grooved Pegboard dominant hand; GP–NDOM, Grooved Pegboard non dominant hand.
1 Time to completion in seconds
2 Number correct
3 Drop in number of words recalled.
a The block design was not performed in Namche so the total RCI scores were calculated without the block design at all assessment points.
https://doi.org/10.1371/journal.pone.0174277.t005
Caudwell Xtreme Everest: A study of the effects of environmental hypoxia on cognitive functioning
PLOS ONE | https://doi.org/10.1371/journal.pone.0174277 March 27, 2017 7 / 15
function among trekkers are shown in Fig 1: pronounced decline (16%; N = 29), mild decline
(66%; N = 118) and improvement (18%; N = 33).
Factors related to cognitive decline
Associations with demographic and clinical parameters were examined separately at each
assessment point (for individual and summary RCI scores) and in relation to overall cognitive
trajectories across expedition (mild decline; pronounced decline; improvement).
The gender, education, anthropometric indices (height; weight) and mood (anxiety and
depression symptoms) of the group of participants who exhibited cognitive decline did not
Fig 1. Latent profiles of RCI total scores among trekkers. Error bars represent 95% confidence intervals.
https://doi.org/10.1371/journal.pone.0174277.g001
Table 6. Fit indices for latent profile analysis on RCI total scores.
LL a AIC b BIC c Entropy BLRT d (p value)
1 Class -449.00 909.98 929.14 – –
2 Class -402.49 824.98 856.91 .65 93.00 (< .001)
3 Class -367.62 763.24 807.94 .82 69.74 (< .001)
Note
a Log-likelihood
b Akaike Information Criterion
c Bayesian Information Criterion
d Bootstrapped Likelihood Ratio Test.
https://doi.org/10.1371/journal.pone.0174277.t006
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differ from those who exhibited no such decline. There were a few significant associations
between RCI scores and age, education and mood albeit not consistently for all NP tests and
across all ascent points. Any significant associations of mood and education with cognitive
decline were mainly found at the highest point of ascent (EBC) but not for all cognitive tests.
Anxiety and depression were in the main unrelated to cognitive decline with only a handful of
significant (small-sized) associations between symptoms of anxiety with decline in memory
(r = -.16; p = .035 for RAVLT-T and r = -.15; p = .043 for RAVLT-D) and overall total RCI
summary scores at EBC (r = -.17 p = .032). Symptoms of depression correlated only with
decline in one NP test, namely SD at EBC (r = -.19; p = .011).
The number of years of full time education was found to be inversely associated with
decline in two of the 11 cognitive test scores, i.e. TMT-A (r = -.20; p = .012), STROOP (r =
-.28; p = .001), at EBC. Age, on the other hand, was significantly associated with decline in
TMT-A (r = -.19; p = .015),; TMT-B (r = -.19; p = .014); LCT (r = -.46; p< .0001); SDMT (r =
-.29; p< .0001); BD (r = -.24; p = .003); and total RCI scores (r = -.27; p = .005) and count of
tests showing decline (r = .42; p< .0001) but only at the last assessment point, i.e., return back
to Kathmandu. The greater decline with age on descent to Kathmandu suggests that cognitive
recovery may vary as a function of age.
The symptoms of AMS were associated with decline in some tests, but only at EBC. These
tests were: RAVLT-D (r = -.19; p = .011); COWA (r = -.20; p = .008); STROOP (r = -.15; p =
.045) and Total RCI Summary Scores (r = -.25; p = .001). IQ scores and physiological parame-
ters, i.e. SPB, NIRS, SaO2 (absolute or percentile change relative to baseline) were unrelated to
cognitive decline (p>.05 in all cases). The only physiological variable with significant (albeit
inconsistent) associations with cognitive assessments was DPB. Increased DBP (percentile
change relative to baseline) was significantly associated with decline in COWA (r = -.16; p =
.032) at Namche and decline in SD (r = -.15; p = .038) and BD (r = -.15; p = .039) at EBC.
Analyses on cognitive profiles indicated no significant differences between the three trajec-
tories (mild decline; pronounced decline; improvement) in any of the socio-demographic,
physiological or psychological variables examined.
Discussion
This is the largest prospective study to investigate the impacts of environmental hypoxia on cog-
nitive ability. As expected, absolute cognitive performance improved with experience of repeated
testing in both trekkers and controls. Adjustment for such ‘practice effects’, using RCI method-
ology and profiling of cognitive trajectories across the expedition, provided clear evidence of
overall cognitive impairment across several domains in the group of trekkers exposed to altitude
and environmental hypoxia. Cognitive declines were evident in the group on all NP tasks at the
highest point of ascent, i.e. Everest Base Camp (5,300 m). Of note, whilst cognitive performance
improved on descent from Everest Base Camp to Kathmandu (1,300m), it remained impaired
when compared to pre-trek levels and even to those recorded at greater altitude (Namche:
3,500m) on ascent. Thus, return to lower altitude does not immediately restore the cognitive
effects of exposure to hypoxia. Age was unrelated to RCI-based NP tests or summary scores at
high altitudes (both Namche and Everest Base Camp) but was significant on descent to Kath-
mandu suggesting poorer cognitive recovery in older participants—although whether this per-
sists is not known. This finding is in keeping with other studies where the vulnerability of the
cognitive functioning of older people has been found to be associated with poorer recovery in a
range of conditions including traumatic brain injury and surgery [44, 45].
Cognitive decline was greatest in executive function, complex attention, and verbal skills
[8, 9, 46, 47, 48, 49]. There was a small improvement in psychomotor abilities at 1,300 m
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(Kathmandu) and 3,500 m (Namche) when compared at baseline, but this declined at the high-
est altitude (EBC). Verbal memory did not decline at first ascent testing (Namche; 3,500 m)
yet declines in memory were found at all subsequent testing points. The notion of a threshold
may explain the lack of decline in motor function and memory at altitudes lower than 4,000
m. Motor precision skills reflected in GP are thought to be affected at higher altitudes in com-
parison to motor speed [12]. It has been suggested that a distinct pattern of neuropsychological
change develops above 4,000 m altitude and this is consistent with the cognitive decline in all
cognitive domains at the highest point of ascent (Everest Base Camp at 5,300 m). These find-
ings are in line with the proposed transitional zone at 4000 m for loss of autoregulation in cere-
bral blood flow [50]. Variation in the susceptibility to hypoxia of different brain regions (i.e.
hippocampus, basal ganglia, cerebellum and occipital cortex), each associated with particular
cognitive functions, may also account for the observed pattern of results [51]. An alternative
explanation may relate to differences in test sensitivity and levels of difficulty. Grooved Peg-
board, a test of motor precision, may be considered a less complex task relative to the tests
of attention and executive function deployed in this study. These more complicated tasks
showed deterioration at lower altitudes. The observed declines in cognitive performance at the
lower altitudes cannot be attributed to AMS. AMS symptoms were related to decline in verbal
abilities and executive function only at highest point of ascent (5,300) but not at lower alti-
tudes. There was also no clear physiological pathway as none of measures taken showed reli-
able associations across tests or testing to allow some confidence of a plausible physiological
mechanism.
While cognitive decline was demonstrated for most trekkers, some were unaffected or even
performed better relative to baseline after practice effects were accounted for. However, de-
cline with altitude was the norm for most. This pattern was shown both in analyses of individ-
ual tests as well as overall cognitive profiles across ascent. Such variability is consistent with
that observed in other physiological responses to high altitude. The reasons for such variation
remain unclear. With the exception of differential rates of recovery on descent being related to
age, variability in performance was not consistently explained by socio-demographic charac-
teristics (age, education, smoking), cognitive reserve (i.e., IQ), physiological parameters such
as oxygen saturation levels or time intervals between assessments. It is of note that NP decline
in some tests and on the overall measure of NP was associated with the symptoms of AMS
only at the highest level of ascent. It is possible that the threshold for symptoms of AMS at that
point is of sufficient severity to have a generalised effect including on cognition.
The heterogeneity in cognitive outcomes in individual performance represents a challenge
for prediction in conditions of hypoxia. This is in common with a growing but incomplete
understanding of the mechanisms underlying cognitive decline, resilience or recovery. Whilst
hypoxia itself appears the most cogent explanation of the overall results, the variability can be
attributed to factors such as inflammatory processes, oxidative stress, cortical damage, cumula-
tive effects of repeated ascents, prolonged altitude exposure, immune alterations and fatigue,
sleep disturbances, or psychological stressors [52]. All of these possibilities are highly specula-
tive at this point, but generate potential hypotheses for future research on individual differ-
ences apparent in these results.
A particular strength of the current study is our sample size (the largest to date for such a
study) that allowed the statistical modeling of trajectories of cognitive change; the use of con-
trols matched for age and educational background, so as to control for measurement error and
practice effects; and the use of a comprehensive cognitive battery. Most other studies have
used small samples (that precluded statistical modeling) and limited neuropsychological tests.
The current study adds to the literature in two important ways. First, we have used to model
trajectories of cognitive test scores over incremental exposure to hypobaric hypoxia. The
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results of these analyses reveal that there is heterogeneity in the profiles of change over time in
a large sample av. Second, these results also help to tease apart the relative contributions of
maturation (i.e., normal aging) and practice effects that can affect follow-up test scores.
Our study does, however, have weaknesses. Limitations in carrying equipment to altitude,
and unreliability of power supply, meant that assessments had to be based on oral or written
(pen and paper) NP tests which have been shown to be associated with greater variability than
computerised tests [53].
The control group was recruited opportunistically. The quality of RCI analyses is largely
dependent upon how closely the control group matches the characteristics of the interest
group. Barring randomisation, which would have been ideal yet unfeasible, we have under-
taken careful matching to ensure that any significant differences in performance are not due to
differences in age, education and oxygen saturation levels. It remains possible that there may
be other unmeasured variables that may account for the effects such differences in levels of
exercise between trekkers and control participants. Although none of NP tests were performed
immediately after exercise or reaching designated ascent points so as to reduce possible pro-
ximal effects, differences between trekkers and controls were not directly controlled for.
Although recruiting healthy participants was deemed the best technique to estimate practice
effects, the small sample size of control group and potential differences in levels of exercise as
result of the expedition may limit the accuracy of the calculation of practice effects.
Further work is required to elucidate the mechanisms of cognitive decline in conditions of
acute hypoxia and to account for individual differences in cognitive performance and recovery
rates.
Authors’ translational perspective
The clinical neurocognitive effects of hypoxia manifest in diverse environments–from the agi-
tated patient in the pre-hospital phase, to the deteriorating intensive care patient, to the elderly
octogenarian developing a chest infection and concurrent confusion. By studying the neuro-
cognitive effects of hypoxia on otherwise “healthy” individuals in a prospective manner, this
study aimed to investigate this in a structured way. The results imply that, in some individuals
at least, hypoxia results in a reduced ability to learn. This may link to disorientation in time
and place that is commonly seen in hypoxic patients, particularly in critically ill patients. The
notable predilection to loss of verbal ability may equate to inability to express oneself. Clini-
cally it is often perceived that the elderly are more prone to confusion. In our study age was
significantly associated with decline, and notably with delayed recovery (i.e., return back to the
relative normoxia of Kathmandu). This suggests that cognitive recovery from hypoxia may
persist longer in older people and this chimes with clinical experience of reduced cognitive
resilience and delayed return to normal cognitive function in elderly patients exposed to hyp-
oxia and other pathological stressors. Possibly of greatest importance is the marked heteroge-
neity of cognitive decline. Hypoxia did not have the same effect on everyone–some were more
prone to neurocognitive decline than others. Further studies are needed to help identify bio-
markers of predisposition and response for hypoxia-related cognitive impairment, particularly
in older patients, in order to guide therapy and thereby minimise the magnitude and duration
of impairment.
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